Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000.
Cartwright
K
K
Public Health Laboratory, Gloucester Hospital, Public Health Authority, Gloucester, UK. kcartwright@phls.nhs.uk
Noah
N
N
Peltola
H
H
D002986:Clinical Trials as Topic; D005060:Europe / Q000453:epidemiology; D006801:Humans; D008589:Meningococcal Infections / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000627:therapeutic use*; D009345:Neisseria meningitidis / Q000276:immunology*; D018074:Vaccines, Conjugate / Q000627:therapeutic use*
D022401:Meningococcal Vaccines; D018074:Vaccines, Conjugate; C410218:serogroup C meningococcal conjugate vaccine